Urinary biomarker and treatment mechanism of Rhizoma Alismatis on hyperlipidemia

Biomedical Chromatography

Volumn 31, Issue 4, 2017, Pages

  Miao, Hua ^a   Zhang, Li ^b   Chen, Dan Qian ^a   Chen, Hua ^a   Zhao, Ying Yong ^a   Ma, Shuang Cheng ^c  

^a NORTHWEST UNIVERSITY   (China)

^b XI AN NO 4 HOSPITAL   (China)

^c NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

biomarker; hyperlipidemia; mass spectrometry; Rhizoma alismatis; ultra performance liquid chromatography; urinary metabolomics

Indexed keywords

BIOMARKERS; LEAST SQUARES APPROXIMATIONS; LIQUID CHROMATOGRAPHY; METABOLISM; METABOLITES; MULTIVARIANT ANALYSIS; PHYSIOLOGY;

HIGH DEFINITION; HIGH-FAT-DIET; HYPERLIPIDEMIA; MASS SPECTROMETRY DATA ANALYSIS; METABOLOMICS; QUADRUPOLE/TIME OF FLIGHTS; RHIZOMA ALISMATI; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY BIOMARKERS; URINARY METABOLOMIC;

MASS SPECTROMETRY;

1 HYDROXYPYRENE; 3METHYLURIDINE; 4 AMINOHIPPURIC ACID; 4 HEPTANONE; ASCORBALAMIC ACID; BIOLOGICAL MARKER; CREATININE; CYTIDINE; DEXTRO ARGININE; DIURETIC AGENT; HIPPURIC ACID; HYPOXANTHINE; INDOLE 3 CARBOXYLIC ACID; INDOLELACTIC ACID; METHYLHIPPURIC ACID; N ACETYLNEURAMINIC ACID; PHENYLACETYLGLYCINE; PLANT EXTRACT; PROPIONYLCARNITINE; RHIZOMA ALISMATIS EXTRACT; UNCLASSIFIED DRUG; UROCANIC ACID; XANTHINE; XANTHOSINE; ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; HYPERLIPIDEMIA; LIPID DIET; MALE; METABOLITE; METABOLOMICS; NONHUMAN; PURINE METABOLISM; PYRIMIDINE METABOLISM; QUADRUPOLE MASS SPECTROMETRY; RAT; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; ADVERSE EFFECTS; ALISMA; ANIMAL; BLOOD; CHEMISTRY; HYPERLIPIDEMIAS; LEAST SQUARE ANALYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICINAL PLANT; METABOLISM; MULTIVARIATE ANALYSIS; PROCEDURES; REPRODUCIBILITY; RHIZOME; SPRAGUE DAWLEY RAT; URINE;

ALISMA; ANIMALS; BIOMARKERS; CHOLESTEROL, LDL; CHROMATOGRAPHY, LIQUID; DIET, HIGH-FAT; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LEAST-SQUARES ANALYSIS; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PLANTS, MEDICINAL; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; RHIZOME; TRIGLYCERIDES;

EID: 84991087289     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3829     Document Type: Article

References (52)

1. Berulava, T., Ziehe, M., Klein-Hitpass, L., Mladenov, E., Thomale, J., Rüther, U., & Horsthemke, B. (2013). FTO levels affect RNA modification and the transcriptome. European Journal of Human Genetics, 21, 317–323.
2. Carmella, S. G., Le, K. A., & Hecht, S. S. (2004). Improved method for determination of 1-hydroxypyrene in human urine. Cancer Epidemiology, Biomarkers and Prevention, 13, 1261–1264.
3. Chen, L. L., Hu, Z. F., Ding, X. P., Qi, J., Zhu, D. N., & Yu, B. Y. (2013). Identification and determination of the major triterpenes in Rhizoma Alismatis by HPLC-evaporative light scattering detection and HPLC/electrospray ionization-MS. Journal of AOAC International, 96, 260–264.
4. Chen, D. Q., Feng, Y. L., Tian, T., Chen, H., Yin, L., Zhao, Y. Y., & Lin, R. C. (2014a). Diuretic and anti-diuretic activities of fractions of Alismatis rhizoma. Journal of Ethnopharmacology, 157, 114–118.
5. Chen, H., Miao, H., Feng, Y. L., Zhao, Y. Y., & Lin, R. C. (2014b). Metabolomics in dyslipidemia. Advances in Clinical Chemistry, 66, 101–119.
6. Chen, L., Zhang, J., & Chen, W. N. (2014c). Engineering the Saccharomyces cerevisiae β-oxidation pathway to increase medium chain fatty acid production as potential biofuel. PloS One, 9, e84853.
7. Chen, H., Yuan, B., Miao, H., Tan, Y., Bai, X., Zhao, Y. Y., & Wang, Y. (2015). Urine metabolomics reveals new insights into hyperlipidemia and therapeutic effect of rhubarb. Analytical Methods, 7, 3113–3123.
8. Chen, H., Chen, L., Tang, D. D., Chen, D. Q., Miao, H., Zhao, Y. Y., & Ma, S. C. (2016). Metabolomics reveals hyperlipidemic biomarkers and antihyperlipidemic effect of Poria cocos. Current Metabolomics, 4, 104–115.
9. Daniels, S. R. (2011). Management of hyperlipidemia in pediatrics. Current Opinion in Cardiology, 27, 92–97.
10. Feng, Y. L., Chen, H., Tian, T., Chen, D. Q., Zhao, Y. Y., & Lin, R. C. (2014). Diuretic and anti-diuretic activities of the ethanol and aqueous extracts of Alismatis Rhizoma. Journal of Ethnopharmacology, 154, 386–390.
11. Gu, S., Wang, G., Zha, W., Yan, B., Zhang, Y., Ren, H., … Liu, L. (2010). Metabonomic profiling of liver metabolites by gas chromatography–mass spectrometry and its application to characterizing hyperlipidemia. Biomedical Chromatography, 24, 245–252.
12. Hartmannf, F., Freiberg, E., & Ruge, W. (1962). Indolepatterns in the urine of liver patients. Wiener Klinische Wochenschrift, 40, 721–729.
13. Hecht, S. S., Carmella, S. G., Le, K. A., Murphy, S. E., Li, Y. S., Le, C., … Hatsukami, D. K. (2004). Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine. Cancer Epidemiology, Biomarkers and Prevention, 13, 834–842.
14. Hong, X., Tang, H., Wu, L., & Li, A. (2006). Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. Journal of Pharmacy and Pharmacology, 58, 1391–1398.
15. Idle, J. R., & Gonzalez, F. J. (2009). Metabolomics. Cell Metabolism, 6, 348–351.
16. Ifegwu, C., Osunjaye, K., Fashogbon, F., Oke, K., Adeniyi, A., & Anyakora, C. (2012). Urinary 1-hydroxypyrene as a biomarker to carcinogenic polyaromatic hydrocarbon exposure. Biomarker Cancer, 4, 7–17.
17. 1H NMR-based metabonomic investigation of time-related metabolic trajectories of the plasma, urine and liver extracts of hyperlipidemic hamsters. PloS One, 8,.e66786
18. 1H NMR based metabonomics approach to progression of coronary atherosclerosis in a hamster model. Yao Xue Xue Bao, 4, 495–502.
19. Kristal, B. S., Vigneau-Callahan, K. E., Moskowitz, A. J., & Matson, W. R. (1999). Purine catabolism: links to mitochondrial respiration and antioxidant defenses? Archives of Biochemistry and Biophysics, 370, 22–33.
20. Lee, S. H., Kim, I., & Chung, B. C. (2007). Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease. Clinical Biochemistry, 40, 936–938.
21. Li, J. J., Yang, J., Cui, W. X., Chen, X. Q., Chen, G. L., Wen, X. D., & Wang, Q. (2013). Analysis of therapeutic effect of Ilex hainanensis Merr. extract on nonalcoholic fatty liver disease through urine metabolite profiling by ultraperformance liquid chromatography/quadrupole time of flight mass spectrometry. Evidence-based Complementary and Alternative Medicine, 2013, 451975.
22. Li, S., Jin, S., Song, C., Chen, C., Zhang, Y., Xiang, Y., … Jiang, H. (2016). The metabolic change of serum lysophosphatidylcholines involved in the lipid lowering effect of triterpenes from Alismatis Rhizoma on high-fat diet induced hyperlipidemia mice. Journal of Ethnopharmacology, 177, 10–18.
23. Liebich, H. M. (1983). Gas chromatographic–mass spectrometric determination of total 4-heptanone, a new marker in diabetes mellitus. Journal of Chromatography B, 273, 67–75.
24. Liu, X., Li, S. L., Zhou, Y., Song, J. Z., Zheng, Y. F., Peng, G. P., & Xu, H. X. (2010). Characterization of protostane triterpenoids in Alisma orientalis by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry, 24, 1514–1522.
25. Ma, C., Bi, K. S., Zhang, M., Su, D., Fan, X. X., Ji, W., … Chen, X. H. (2010). Toxicology effects of morning glory seed in rat: a metabonomic method for profiling of urine metabolic changes. Journal of Ethnopharmacology, 130, 134–142.
26. Miao, H., Chen, H., Zhang, X., Yin, L., Chen, D. Q., Cheng, X. L., … Wei, F. (2014). Urinary Metabolomics on the biochemical profiles in diet-induced hyperlipidemia rat using ultraperformance liquid chromatography coupled with quadrupole time-of-flight SYNAPT high-definition mass spectrometry. Journal of Analytical Methods in Chemistry, 2014, 184162.
27. Miao, H., Chen, H., Pei, S., Bai, X., Vaziri, N. D., & Zhao, Y. Y. (2015a). Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia. Chemico-Biological Interactions, 228, 79–87.
28. Miao, H., Li, M. H., Zhang, X., Yuan, S. J., Ho, C. C., & Zhao, Y. Y. (2015b). The antihyperlipidemic effect of Fu-Ling-Pi is associated with abnormal fatty acid metabolism as assessed by UPLC-HDMS-based lipidomics. RSC Advances, 5, 64208–64219.
29. Miao, H., Zhao, Y. H., Vaziri, N. D., Tang, D. D., Chen, H., Chen, H., … Zhao, Y. Y. (2016). Lipidomics biomarkers of diet-induced hyperlipidemia and its treatment with Poria cocos. Journal of Agricultural and Food Chemistry, 64, 969–979.
30. Nakamura, K., Miyoshi, T., Yunoki, K., & Ito, H. (2016). Postprandial hyperlipidemia as a potential residual risk factor. Journal of Cardiology, 67, 335–339.
31. Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29, 1181–1189.
32. O'Keefe, J. H., & Bell, D. S. (2007). Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. American Journal of Cardiology, 100(5), 899–904.
33. Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., … Rioux, K. P. (2013). Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology, 11, 868–875.
34. Son, N., Hur, H. J., Sung, M. J., Kim, M. S., Hwang, J. T., Park, J. H., … Kim, H. J. (2012). Liquid chromatography–mass spectrometry-based metabolomic analysis of livers from aged rats. Journal of Proteome Research, 11, 2551–2558.
35. Sperner-Unterweger, B., Neurauter, G., Klieber, M., Kurz, K., Meraner, V., Zeimet, A., & Fuchs, D. (2011). Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers. Immunobiology, 216, 296–301.
36. Tavazzi, B., Lazzarino, G., Leone, P., Amorini, A. M., Bellia, F., Janson, C. G., … Giardina, B. (2005). Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism. Clinical Biochemistry, 38, 997–1008.
37. Wahl, H. G., Hoffmann, A., Luft, D., & Liebich, H. M. (1999). Analysis of volatile organic compounds in human urine by headspace gas chromatography–mass spectrometry with a multipurpose sampler. Journal of Chromatography A, 847, 117–125.
38. Wyss, M., & Kaddurah-Daouk, R. (2000). Creatine and creatinine metabolism. Physiological Reviews, 80, 1107–1213.
39. Zhang, F., Jia, Z., Gao, P., Kong, H., Li, X., Chen, J., … Xu, G. (2009a). Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap–time of flight mass spectrometry. Talanta, 79, 836–844.
40. Zhang, Q., Wang, G. J., Du, Y., Xiang, B. R., Deng, H. S., A, J. Y., & B, M. (2009b). Application of several pattern recognition methods in metabonomic research of rat hyperlipidemia. Journal of China Pharmaceutical University, 40, 448–453.
41. Zhang, A., Sun, H., Han, Y., Yan, G., & Wang, X. (2013a). Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system. PloS One, 8,.e64381
42. Zhang, T., Wu, X., Ke, C., Yin, M., Li, Z., Fan, L., … Li, K. (2013b). Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. Journal of Proteome Research, 12, 505–512.
43. Zhang, Z. H., Wei, F., Vaziri, N. D., Cheng, X. L., Bai, X., Lin, R. C., & Zhao, Y. Y. (2015). Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Scientific Reports, 5, 14472.
44. Zhao, Y. Y. (2013). Metabolomics in chronic kidney disease. Clinica Chimica Acta, 422, 59–69.
45. E application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chemico-Biological Interactions, 215, 7–16.
46. E data collection technique. Biomarkers, 17, 721–729.
47. Zhao, Y. Y., Cheng, X. L., Wei, F., Xiao, X. Y., Sun, W. J., Zhang, Y., & Lin, R. C. (2012b). Serum metabonomics study of adenine-induced chronic renal failure rat by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Biomarkers, 17, 48–55.
48. Zhao, Y. Y., Liu, J., Cheng, X. L., Bai, X., & Lin, R. C. (2012c). Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clinica Chimica Acta, 413, 642–649.
49. E data collection technique. Process Biochemistry, 47, 1980–1987.
50. E. Journal of Proteome Research, 12, 692–703.
51. Zhao, Y. Y., Li, H. T., Feng, Y. L., Bai, X., & Lin, R. C. (2013b). Urinary metabonomic study of the surface layer of Poria cocosas an effective treatment for chronic renal injury in rats. Journal of Ethnopharmacology, 148, 403–410.
52. Zhao, Y. Y., Cheng, X. L., Vaziri, N. D., Liu, S., & Lin, R. C. (2014). UPLC-based metabonomics applications for discovering biomarkers of diseases in clinical chemistry. Clinical Biochemistry, 47, 16–26.